Optimize postprandial glycemic control with tailored exercise prescriptions

Researchers elucidate various exercise parameters influence post-meal glucose responses in healthy and diabetic individuals.

Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024

Wall Street analysts tipped 2024 as the year that medtech dealmaking would return after a two-year slowdown when companies were forced to navigate a tough economic

March 28, 2024

FDA finalizes Voluntary Malfunction Summary Reporting guidance

Dive Brief: The Food and Drug Administration finalized guidance on Thursday for its Voluntary Malfunction Summary Reporting (VMSR) program for medical device manufacturers. The program,

August 30, 2024

FDA authorizes Pi-Cardia’s valve-in-valve TAVR device

Dive Brief: Pi-Cardia received Food and Drug Administration clearance for a device designed to reduce the risk of coronary obstruction in valve-in-valve transcatheter aortic valve

October 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.